CAMSAP2 and non-small cell lung carcinoma: In brief, in the study, it was found that CircSOD2 is elevated in tumors and cells of NSCLC patients and its silencing can partially curb NSCLC cell development through the CircSOD2/miR-2355-5p/CAMSAP2 ceRNA pathway, thereby refraining NSCLC malignant transformation.